MOROLIMUMAB
UNII R6LF24NKU4

Substance Identification & Data

This profile provides standardized clinical and technical data for Morolimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R6LF24NKU4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 202833-07-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
R6LF24NKU4
CAS Registry Number
202833-07-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MOROLIMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188621
National Cancer Institute reference terminology for clinical and research data.
INN ID
7646
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Morolimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MOROLIMUMAB

Common Names & Synonyms

HUMAN MONOCLONAL IGG1 ANTIBODY AGAINST HUMAN RHESUS-D ANTIGEN
MMUNOGLOBULIN G1, ANTI-(HUMAN RH(D) ANTIGEN) (HUMAN MONOCLONAL CLONE 190/31 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CLONE 190/31 .KAPPA.-CHAIN, DIMER
MOROLIMUMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus